Cargando…

Editorial: The role of transcription factors, stem cell markers and epigenetics contributing to chemoresistance in brain cancers

Detalles Bibliográficos
Autores principales:	Castresana, Javier S., Shahi, Mehdi H., Sharma, Ashok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505812/ https://www.ncbi.nlm.nih.gov/pubmed/37727217 http://dx.doi.org/10.3389/fonc.2023.1263469

Ejemplares similares

Role of Circular RNA in Brain Tumor Development
por: Ahmed, Swalih P., et al.
Publicado: (2022)

A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma
por: Hasan, Hera, et al.
Publicado: (2023)

Editorial: New strategies to tackle chemoresistance in cancer
por: De Marco, Carmela, et al.
Publicado: (2022)

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Editorial: The Role of Epigenetic Modifications in Cancer Progression
por: Fujimura, Atsushi, et al.
Publicado: (2021)

Editorial: Epigenetic and metabolic regulation of primary and metastatic brain cancers
por: Gimple, Ryan C., et al.
Publicado: (2023)

Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression
por: Yang, Yongyong, et al.
Publicado: (2023)

Editorial: Altered epigenetic modification mediated dysregulated transcriptional networks in drug resistance
por: Brunetti, Bryce, et al.
Publicado: (2023)

Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
por: Singh, Shivam, et al.
Publicado: (2023)

Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistance
por: Raman, Dayanidhi, et al.
Publicado: (2023)

Editorial: Epigenetic Modifications in Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2021)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis
por: Li, Yonghui, et al.
Publicado: (2022)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Editorial: Epigenetics and cellular plasticity in glioblastoma
por: Lo, Hui-Wen, et al.
Publicado: (2023)

Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis
por: Ma, Lisi, et al.
Publicado: (2020)

Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance
por: Huang, Chung-Yen, et al.
Publicado: (2019)

Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
por: Sridharan, Sangita, et al.
Publicado: (2019)

Editorial: GBM stem cells and the brain tumor microenvironment
por: Li, Yunqing, et al.
Publicado: (2023)

Editorial: Epigenetics and molecular genetics of rare tumors
por: Tognon, Mauro, et al.
Publicado: (2022)

Editorial: Epigenetic insights into diagnostic and therapeutic applications
por: Fratta, Elisabetta, et al.
Publicado: (2023)

Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
por: Gaggianesi, Miriam, et al.
Publicado: (2021)

CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer
por: Wessolly, Michael, et al.
Publicado: (2022)

Editorial: The Role of the Immune Response in Brain Metastasis
por: Sibson, Nicola R., et al.
Publicado: (2022)

Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application
por: Lin, Hon-Yi, et al.
Publicado: (2023)

Editorial: The interconnection between epigenetic modifications and the tumor microenvironment
por: He, Siyuan, et al.
Publicado: (2023)

Glioblastoma and MiRNAs
por: Ahmed, Swalih P., et al.
Publicado: (2021)

PIWIL1 Drives Chemoresistance in Multiple Myeloma by Modulating Mitophagy and the Myeloma Stem Cell Population
por: Wang, Yajun, et al.
Publicado: (2022)

Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo
por: Radin, Daniel P., et al.
Publicado: (2022)

Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes
por: Raman, Dayanidhi, et al.
Publicado: (2020)

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
por: Li, Yonghui, et al.
Publicado: (2023)

The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance
por: Zhao, QingYi, et al.
Publicado: (2022)

Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma
por: Shahi, Mehdi H, et al.
Publicado: (2010)

Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity
por: LI, SULAN, et al.
Publicado: (2015)

Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer
por: Yan, Shushan, et al.
Publicado: (2022)

Editorial: The role of Helicobacter pylori in gastric carcinogenesis
por: Torres, Javier, et al.
Publicado: (2023)

LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a
por: Li, Zhi-hua, et al.
Publicado: (2020)

Phase separation in epigenetics and cancer stem cells
por: Xiao, Chanchan, et al.
Publicado: (2022)

Stem Cell Markers in Neuroblastoma—An Emerging Role for LGR5
por: Forgham, Helen, et al.
Publicado: (2015)

The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
por: Liu, Chang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pb95v6ensrcmf049p24954hvpc